Safety and efficacy of anticoagulation therapy with low molecular weight heparin for portal vein thrombosis in patients with liver cirrhosis

Journal of Clinical Gastroenterology

Volumn 44, Issue 6, 2010, Pages 448-451

  Amitrano, Lucio ^a   Guardascione, Maria Anna ^a   Menchise, Antonella ^a   Martino, Rossana ^a   Scaglione, Mariano ^a   Giovine, Sabrina ^a   Romano, Luigia ^a   Balzano, Antonio ^a  

^a CARDARELLI HOSPITAL   (Italy)

Author keywords

anticoagulation; cirrhosis; heparin; portal vein thrombosis

Indexed keywords

ENOXAPARIN; LOW MOLECULAR WEIGHT HEPARIN; ANTICOAGULANT AGENT;

ACUTE ABDOMEN; ADULT; ANTICOAGULANT THERAPY; ARTICLE; CLINICAL ARTICLE; DRUG EFFICACY; DRUG SAFETY; ESOPHAGUS VARICES BLEEDING; HUMAN; LIVER CIRRHOSIS; PORTAL VEIN THROMBOSIS; PRIORITY JOURNAL; RECANALIZATION; STOMACH VARICES; AGED; COMPLICATION; FEMALE; MALE; MIDDLE AGED; PORTAL VEIN; TREATMENT OUTCOME; VENOUS THROMBOSIS;

AGED; ANTICOAGULANTS; FEMALE; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PORTAL VEIN; TREATMENT OUTCOME; VENOUS THROMBOSIS;

EID: 77953762848     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/MCG.0b013e3181b3ab44     Document Type: Article

References (21)

1. Francoz C, Belghiti J, Vilgrain V, et al. Splanchnic vein thrombosis in candidates for liver transplantation: usefulness of screening and anticoagulation. Gut. 2005;54:691-697.
2. Charco R, Fuster J, Fondevila J, et al. Portal vein thrombosis in liver transplantation. Transplantation Proceedings. 2005;37: 3904-3905.
3. Wanless IR, Wonh F, Blendis LM, et al. Hepatic and portal vein thrombosis in cirrhosis: possible role in development of parenchimal extinction and portal hypertension. Hepatology. 1995; 21:1238-1247.
4. Amitrano L, Guardascione MA, Brancaccio V, et al. Risk factors and clinical presentation of portal vein thrombosis in patients with liver cirrhosis. J Hepatol. 2004;40:736-741.
5. Yerdel MA, Gunson B, Mirza D, et al. Portal vein thrombosis in adults undergoing liver transplantation. Transplantation. 2000;69:1873-1881.
6. Condat B, Pessione F, Hillaire S, et al. Current outcome of portal vein thrombosis in adults: risk and benefits of anticoagulant therapy. Gastroenterology. 2001;120:490-497.
7. Condat B, Pessione F, Denninger MH, et al. Recent portal and mesenteric venous thrombosis: Increased recognition and frequent recanalization on anticoagulant therapy. Hepatology. 2000;32:466-470.
8. Amitrano L, Guardascione MA, Scaglione M, et al. Prognostic factors in non cirrhotic patients with splanchnic vein thrombosis. Am J Gastroenterol. 2007;102:2464-2470. (Pubitemid 47631782)
9. Plessier A, Murad SD, Hernandez-Guerra M, et al. A prospective multicentric follow-up study on 105 patients with acute portal vein thrombosis (PVT): results from the European network for vascular disorders of the liver (EN-VIE). Hepatology. 2007;46(suppl 1):310A.
10. Tripodi A, Salerno F, Chantarangkul V, et al. Evidence of normal thrombin generation in cirrhosis despite abnormal conventional coagulation tests. Hepatology. 2005;41:553-558.
11. Northup PG, McMahon MM, Parker Ruhl A, et al. Coagulopathy does not fully protect hospitalized cirrhosis patients from peripheral venous thromboembolism. Am J Gastroenterol. 2006;101:1524-1528.
12. DeLeve Ld, Valla DC, Garcia-Tsao G. Vascular disorders of the liver. Hepatology. 2009;49:1729-1764.
13. Kearon C, Kahn SR, Agnelli G, et al, American College of Chest Physicians. Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. 8th ed. Chest. 2008;133(6 suppl):454S-545S. (Pubitemid 351892971)
14. Caldwell SH, Hoffman M, Lisman T, et al. Coagulation disorders and hemostasis in liver disease: pathophysiology and critical assessment of current management. Hepatology. 2006; 44:1039-1046.
15. Northup PG, Sundaram V, Fallon MB, et al. Hypercoagulation and thrombophilia in liver disease. J Thromb Haemost. 2008;6:2-9.
16. Valla DC. Thrombosis and anticoagulation in liver disease. Hepatology. 2008;47:1384-1393.
17. Blum U, Haag K, Rossle M, et al. Non cavernomatous portal vein thrombosis in hepatic cirrhosis: treatment with transjugular intrahepatic portosystemic shunt and local thrombolysis. Radiology. 1995;195:153-157.
18. Senzolo M, Tibbals J, Cholongitas E, et al. Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with and without cavernous transformation. Aliment Pharmacol Ther. 2006;15:767-775.
19. Romero-G-mez M, Gutierrez-Tous R, Delgado-Mije D. Anticoagulation therapy for recent portal vein thrombosis in a patient with liver cirrhosis suffering from variceal rebleeding. Gastroenterology. 2001;120:490-497.
20. Ageno W, Squizzato A. Prophylaxis and treatment of venous thromboembolism in patients with cancer. Intern Emerg Med. 2006;1:260-262.
21. D'Amico G, de Franchis R. Upper digestive bleeding in cirrhosis. Post-therapeutic outcome and prognostic indicators. Hepatology. 2003;38:599-612.